A Study of LY3209590 in Participants With Type 2 Diabetes

NCT03367377 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY3209590
DRUG: Insulin Glargine

Sponsor

Eli Lilly and Company